Perspective Therapeutics, Inc. - 10-Q Filing
Perspective Therapeutics, Inc. reports Q3 financial results including research and development expense trends and fair value disclosures for various debt securities.
Tickers: $CATX
Perspective Therapeutics, Inc. reports Q3 financial results including research and development expense trends and fair value disclosures for various debt securities.
Tickers: $CATX